ym 529 has been researched along with Glioblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hironaka, Y; Matsuda, R; Motoyama, Y; Nakagawa, I; Nakamura, M; Nakase, H; Nakazawa, T; Nishimura, F; Omoto, K; Ouji, Y; Park, YS; Takeshima, Y; Tamura, K; Tanaka, Y; Tsujimura, T; Yamada, S; Yokota, H; Yoshikawa, M | 1 |
1 other study(ies) available for ym 529 and Glioblastoma
Article | Year |
---|---|
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.
Topics: Amino Acid Chloromethyl Ketones; Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase Inhibitors; Cell Count; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Female; Glioblastoma; Humans; Imidazoles; Intraepithelial Lymphocytes; Male; Mice, Inbred NOD; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |